We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+47.05%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$442M
AUM Growth
+$39.9M
Cap. Flow
-$47.3M
Cap. Flow %
-10.69%
Top 10 Hldgs %
74.18%
Holding
92
New
10
Increased
24
Reduced
15
Closed
28
Avg Time Held
5.8 quarters
Top 10 Avg Time Held
5.8 quarters
Top 20 Avg Time Held
5.2 quarters

Top Buys

Rank Stock Value
1
SMR icon
NuScale Power
SMR
+$7.43M
2
ARQT icon
Arcutis Biotherapeutics
ARQT
+$3.57M
3
MRNA icon
Moderna
MRNA
+$2.01M
4
IONQ.WS icon
IonQ Inc Warrants
IONQ.WS
+$1.9M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$1.55M

Top Sells

Rank Stock Value
1
ASTS icon
AST SpaceMobile
ASTS
+$17.3M
2
DDOG icon
Datadog
DDOG
+$7.57M
3
AMD icon
Advanced Micro Devices
AMD
+$7.22M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.63M
5
PLTR icon
Palantir
PLTR
+$6.12M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.85%
2 Healthcare 24.76%
3 Technology 23.63%
4 Communication Services 14.68%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TSLA icon
1
Tesla
TSLA
$1.48T
$88.8M 20.1%
220,000
+4,000
+2% +$1.29M
2022 Q4
8 quarters
SPOT icon
2
Spotify
SPOT
$108B
$64.9M 14.68%
145,000
-4,000
-3% -$1.71M
2021 Q4
12 quarters
SHOP icon
3
Shopify
SHOP
$227B
$44.1M 9.99%
415,000
– –
2021 Q4
12 quarters
AMZN icon
4
Amazon
AMZN
$2.79T
$30.9M 7%
141,000
– –
2022 Q3
9 quarters
PLTR icon
5
Palantir
PLTR
$501B
$28M 6.33%
370,000
-105,000
-22% -$6.12M
2023 Q2
6 quarters
SE icon
6
Sea Limited
SE
$58.8B
$22.3M 5.04%
210,000
– –
2023 Q2
6 quarters
PRQR icon
7
ProQR Therapeutics
PRQR
$209M
$13.2M 2.99%
4,985,633
-646,755
-11% -$2.05M
2021 Q4
12 quarters
QURE icon
8
uniQure
QURE
$1.48B
$13.1M 2.97%
742,162
-2,754
-0.4% -$23.8K
2021 Q4
12 quarters
SNOW icon
9
Snowflake
SNOW
$126B
$11.6M 2.62%
75,000
-20,000
-21% -$2.82M
2021 Q4
12 quarters
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$1.47B
$10.9M 2.46%
258,380
+15,868
+7% +$787K
2021 Q4
12 quarters
NVDA icon
11
NVIDIA
NVDA
$5.52T
$9.8M 2.22%
73,000
– –
2023 Q1
7 quarters
IONS icon
12
Ionis Pharmaceuticals
IONS
$7.04B
$9.33M 2.11%
266,794
+16,050
+6% +$600K
2021 Q4
12 quarters
ITCI icon
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.11M 1.84%
97,154
-20,829
-18% -$1.71M
2023 Q2
6 quarters
MRK icon
14
Merck
MRK
$350B
$7.22M 1.63%
72,611
+12,500
+21% +$1.29M
2021 Q4
12 quarters
ARWR icon
15
Arrowhead Research
ARWR
$8.21B
$7.16M 1.62%
380,586
+47,230
+14% +$973K
2021 Q4
12 quarters
NET icon
16
Cloudflare
NET
$124B
$6.46M 1.46%
60,000
– –
2021 Q4
12 quarters
SMR icon
17
NuScale Power
SMR
$2.66B
$6.45M 1.46%
+360,001
New +$7.43M
2024 Q4
0 quarters
AXSM icon
18
Axsome Therapeutics
AXSM
$8.19B
$5.27M 1.19%
62,232
-18,000
-22% -$1.66M
2023 Q1
7 quarters
RCKT icon
19
Rocket Pharmaceuticals
RCKT
$252M
$5M 1.13%
397,650
+102,850
+35% +$1.55M
2022 Q2
10 quarters
ZLAB icon
20
Zai Lab
ZLAB
$2.59B
$4.85M 1.1%
185,062
-30,562
-14% -$848K
2021 Q4
12 quarters
ARQT icon
21
Arcutis Biotherapeutics
ARQT
$3.28B
$4.54M 1.03%
+325,709
New +$3.57M
2024 Q4
0 quarters
IONQ.WS icon
22
DELISTED
IonQ Inc Warrants
IONQ.WS
$3.9M 0.88%
+128,001
New +$1.9M
2024 Q4
0 quarters
MRNA icon
23
Moderna
MRNA
$86.3B
$3.43M 0.78%
82,476
+41,994
+104% +$2.01M
2022 Q1
11 quarters
CPNG icon
24
Coupang
CPNG
$27.2B
$3.12M 0.71%
141,900
-60,000
-30% -$1.47M
2024 Q1
3 quarters
ACAD icon
25
Acadia Pharmaceuticals
ACAD
$3.21B
$2.72M 0.62%
148,400
– –
2024 Q1
3 quarters
1
2 3 4

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Privium Fund Management held 92 positions worth $442M, up 9.9% from $402M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Privium Fund Management withdrew a net $47.3M in Q4 2024, closing 28 positions and reducing 15 holdings. Its most notable exit was Datadog, an estimated $7.57M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Privium Fund Management opened a new position in NuScale Power worth $6.45M.

  • Privium Fund Management's largest Q4 2024 buy was NuScale Power: 360,001 shares worth $6.45M.
  • Privium Fund Management added most to Moderna in Q4 2024, an estimated $2.01M increase.
  • Privium Fund Management's biggest Q4 2024 reduction was AST SpaceMobile, cutting an estimated $17.3M.
  • Privium Fund Management fully exited Datadog in Q4 2024, selling an estimated $7.57M.
  • Privium Fund Management's ten largest holdings make up 74% of its $442M portfolio in Q4 2024.
  • Privium Fund Management opened 10 new positions and closed 28 in Q4 2024.
  • Privium Fund Management's portfolio value rose 9.9% quarter-over-quarter to $442M.

Based on Privium Fund Management's 13F filing for Q4 2024, filed 11 Feb 2025.